Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2020

Nov 19, 2020

32227_dirs_2020-11-18_9c5ea365-7f42-4910-b078-23d8b4c30e99.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-11-16

Reporting Person: HIPP RAYMOND R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-16 Common Stock S 70000 $42.28 Disposed 66800 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $7.27 2022-05-25 Common Stock (3334.0) 3334 Direct
Stock Option (Right to Buy) $22.52 2026-06-06 Common Stock (4269.0) 4269 Direct
Stock Option (Right to Buy) $28.54 2027-05-28 Common Stock (3448.0) 3448 Direct

Footnotes

F1: On May 25, 2017, Mr. Hipp was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.